J.B. Chemicals and Pharmaceuticals Ltd – Q2FY25 Result Update – SMIFS Institutional Research J.B. Chemicals and Pharmaceuticals Ltd - Q2FY25 Result Update - SMIFS Institutional Research Post navigation Previous Previous post: J.B. Chemicals is well-positioned to capitalize on immediate growth opportunities. Buy for target price of ₹2217 (19% upside): SMIFS Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Current ye@r * Leave this field empty